A carregar...
PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT
Among epileptic encephalopathies, the Lennox–Gastaut syndrome is considered to be one of the most severe. It is a childhood-onset disease that leads to early disability and mental retardation and is associated with significant costs of medical care and patient nursing. In the Russian Federation, the...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
IRBIS LLC
2016-04-01
|
| Colecção: | Фармакоэкономика |
| Assuntos: | |
| Acesso em linha: | https://www.pharmacoeconomics.ru/jour/article/view/132 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|